ArticleArXiv2025
Roadmap for using large language models (LLMs) to accelerate cross-disciplinary research with an example from computational biology.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
Abstract
Large language models (LLMs) are powerful artificial intelligence (AI) tools transforming how research is conducted. However, their use in research has been met with skepticism, due to concerns about hallucinations, biases and potential harms to research. These emphasize the importance of clearly understanding the strengths and weaknesses of LLMs to ensure their effective and responsible use. Here, we present a roadmap for integrating LLMs into cross-disciplinary research, where effective communication, knowledge transfer and collaboration across diverse fields are essential but often challenging. We examine the capabilities and limitations of LLMs and provide a detailed computational biology case study (on modeling HIV rebound dynamics) demonstrating how iterative interactions with an LLM (ChatGPT) can facilitate interdisciplinary collaboration and research. We argue that LLMs are best used as augmentative tools within a human-in-the-loop framework. Looking forward, we envisage that the responsible use of LLMs will enhance innovative cross-disciplinary research and substantially accelerate scientific discoveries.
Identifiers
41019206PMC12461818What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.